Efstratia Papoutselou

Efstratia Papoutselou is a Clinical Development Scientist and Patient and Public Involvement Lead at Rinri Therapeutics since January 2023. Concurrently, Efstratia serves as a Research Fellow, Research Associate, and Assistant Program Coordinator at the University of Nottingham, contributing to the Asymptomatic CV-19 Testing Service Team since January 2021. Previously, Efstratia coordinated the nationwide delivery of Afasic's 'Secondary Starter' summer transition course program for children with speech, language, and communication needs from March 2021 to December 2023. Efstratia holds a PhD in Neuroscience from the University of Nottingham, an MS in Experimental Neuroscience from Imperial College London, and two BS degrees in Neuroscience and Neurobiology and Behavior from King's College London and the University of California, Davis, respectively.